INS and dementia: In addition to discussing the underlying mechanisms of insulin resistance in the CNS, this review provided an update on the efficacy of antidiabetic drugs (with a focus on insulin) as therapeutics for dementia as well as explored the possibility of the use of novel small-molecule mimetics, including insulin mimetics.